Similar NF-κB gene signatures in TNF-α treated human endothelial cells and breast tumor biopsies

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Perrot Applanat, Martine ^a,b   Vacher, Sophie ^c   Toullec, Aurore ^a,b   Pelaez, Irma ^a,b   Velasco, Guillaume ^a,b   Cormier, Françoise ^b,d   Saad, Hanan El Sheikh ^a,b   Lidereau, Rosette ^c   Baud, Véronique ^b,d   Bièche, Ivan ^b,c  

^a Hôpital Lariboisière   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSTITUT CURIE   (France)

^d INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; I KAPPA B; MESSENGER RNA; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; ESTROGEN RECEPTOR ALPHA, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RECEPTOR;

AGED; APOPTOSIS REGULATOR GENE; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST CARCINOGENESIS; CD40 GENE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE ACTIVATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE SILENCING; GM CSF GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACELLULAR SIGNALING; MCF GENE; MICROVASCULATURE; NF KAPPAB GENE; NFKB1 GENE; NFKB2 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; P100 GENE; P52 GENE; RELB GENE; RNA INTERFERENCE; TNF ALPHA GENE; TNFAIP3 GENE; TNFRSF10B GENE; TUMOR VASCULARIZATION; UNINDEXED SEQUENCE; UPREGULATION; BIOPSY; BREAST TUMOR; DRUG EFFECT; GENETICS; KINETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; TIME; WESTERN BLOTTING;

AGED; BIOPSY; BLOTTING, WESTERN; BREAST NEOPLASMS; ENDOTHELIAL CELLS; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KINETICS; MICROVESSELS; MIDDLE AGED; NF-KAPPA B; PROGNOSIS; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; RNA, SMALL INTERFERING; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79960016588     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021589     Document Type: Article

References (57)

1. Tracey KJ, Cerami A, (1993) Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 9: 317-343.
2. Baud V, Karin M, (2001) Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 11: 372-377.
3. Locksley RM, Killeen N, Lenardo MJ, (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104: 487-501.
4. Mocellin S, Rossi CR, Pilati P, Nitti D, (2005) Tumor necrosis factor, cancer and anticancer therapy. Cytokine Growth Factor Rev 16: 35-53.
5. Pahl HL, (1999) Activators and target genes of Rel/NF-kappa B transcription factors. Oncogene 18: 6853-6866.
6. Karin M, Lin A, (2002) NF-kappa B at the crossroads of life and death. Nat Immunol 3: 221-227.
7. Hayden MS, Ghosh S, (2004) Signalling to NF-kappa B. Genes Dev 18: 2195-2224.
8. Baud V, Karin M, (2009) Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nature Reviews Drug Discovey 8 (1): 33-40.
9. Dejardin E, Droin NM, Delhase M, Haas E, Cao Y, et al. (2002) The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 17 (4): 525-535.
10. Claudio E, Brown K, Park S, Wang H, (2002) Siebenlist UBAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat Immunol 3 (10): 958-965.
11. Derudder E, Dejardin E, Pritchard LL, Green DR, Korner M, et al. (2003) RelB/p50 dimers are differentially regulated by tumor necrosis factor-alpha and lymphotoxin-beta receptor activation: critical roles for p100. J Biol Chem 278 (26): 23278-23284.
12. Vanden Berghe W, Vermeulen L, De Wilde G, De Bosscher K, Boone E, et al. (2000) Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6. Biochem Pharmacol 60: 1185-1195.
13. Krishnaswamy G, Smith JK, Mukkamala R, Hall K, Joyner W, et al. (1998) Multifunctional cytokine expression by human coronary endothelium and regulation by monokines and glucocorticoids. Microvasc Res 55: 189-200.
14. Zhou J, Jin Y, GaoY, Wang H, Hu G, et al. (2002) Genomic-scale analysis of gene expression profiles in TNF-alpha treated human umbilical vein endothelial cells. Inflamm Res 51: 332-341.
15. Zhao RZ, Chen X, Yao Q, Chen C, (2005) TNF-alpha induces interleukin-8 and endothelin-1 expression in human endothelial cells with different redox pathways. Biochem Biophys Res Commun 327: 985-992.
16. Hou J, Baichwal V, Cao Z, (1994) Regulatory elements and transcription factors controlling basal and cytokine-induced expression of the gene encoding intercellular adhesion molecule 1. Proc Natl Acad Sci U S A 91: 11641-11645.
17. Kuldo JM, Westra J, Asgeirsdottir SA, Kok RJ, Oosterhuis K, et al. (2005) Differential effects of NF-{kappa}B and p38 MAPK inhibitors and combinations thereof on TNF-{alpha}- and IL-1{beta}-induced proinflammatory status of endothelial cells in vitro. Am J Physiol Cell Physiol 289: C1229-1239.
18. Ledebur HC, Parks TP, (1995) Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-kappa B site and p65 homodimers. J Biol Chem 270: 933-943.
19. Viemann D, Goebeler M, Schmid S, Nordhues U, Klimmek K, et al. (2006) TNF induces distinct gene expression programs in microvascular and macrovascular human endothelial cells. J Leukoc Biol 80 (1): 174-185.
20. Karin M, CaoY, Greten FR, Li ZW, (2002) NF-kappa B in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2: 301-310.
21. Aggarwal BB, (2004) Nuclear factor-kappaB: the enemy within. Cancer Cell 6: 203-208.
22. Coussens LM, Werb Z, (2002) Inflammation and cancer. Nature 420: 860-867.
23. Baldwin AS, (2001) Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest 107: 241-246.
24. Shishodia S, Aggarwal BB, (2004) Nuclear factor-kappa B activation mediates cellular transformation, proliferation, invasion angiogenesis and metastasis of cancer. Cancer Treat Res 119: 139-173.
25. Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, et al. (1997) Aberrant nuclear factor-kappa B/Rel expression and the pathogenesis of breast cancer. J Clin Invest 100: 2952-2960.
26. Jaffe EA, Nachman RL, Becker CG, Minick CR, (1973) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52: 2745-2756.
27. Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, et al. (1997) Novel inhibitors of cytokine-induced IkappaB alpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 272 (34): 21096-21103.
28. Sors A, Jean-Louis F, Bégué E, Parmentier L, Dubertret L, et al. (2008) Inhibition of IkappaB kinase subunit 2 in cutaneous T-cell lymphoma down-regulates nuclear factor-kappaB constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents. Clin Cancer Res 14 (3): 901-911.
29. Levkau B, Scatena M, Giachelli CM, Ross R, Raines EW, (1999) Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-kappa B loop. Nat Cell Biol.1 (4): 227-233.
30. Rossol M, Meusch U, Pierer M, Kaltenhäuser S, Häntzschel H, et al. (2007) Interaction between transmembrane TNF and TNFR1/2 mediates the activation of monocytes by contact with T cells. J Immunol 179 (6): 4239-4248.
31. Kieusseian A, Chagraoui J, Kerdudo C, Mangeot PE, Gage PJ, et al. (2006) Expression of Pitx2 in stromal cells is required for normal hematopoiesis. Blood 2: 492-500.
32. Jacque E, Tchenio T, Piton G, Romeo PH, Baud V, (2005) RelA repression of RelB activity induces selective gene activation downstream of TNF receptors. Proc Natl Acad Sci U S A 102 (41): 14635-14640.
33. Bieche I, Parfait B, Laurendeau I, Girault I, Vidaud M, et al. (2001) Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer. Oncogene 20: 8109-8115.
34. Bloom HJ, Richardson WW, (1957) Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11: 359-377.
35. Bieche I, Lerebours F, Tozlu S, Espie M, Marty M, et al. (2004) Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature. Clin Cancer Res 10: 6789-6795.
36. Ten haguen TL, Seynhaeve AL, Eggermont AM, (2008) Tumor necrosis factor-mediated interactions between inflammatory response and tumor vascular bed. Immunol Rev 222: 299-315.
37. Wosik K, Biernacki K, Khouzam MP, Prat A, (2007) Death receptor expression and function at the human blood brain barrier. J Neurol Sci 259 (1-2): 53-60.
38. Goebeler M, Gillitzer R, Kilian K, Utzel K, Bröcker EB, et al. (2001) Multiple signaling pathways regulate NF-kappaB-dependent transcription of the monocyte chemoattractant protein-1 gene in primary endothelial cells. Blood 97: 46-55.
39. Bernardini G, Ribatti D, Spinetti G, Morbidelli L, Ziche M, et al. (2003) Analysis of the role of chemokines in angiogenesis. J Immunol Methods 273: 83-101.
40. Saji H, Koike M, Yamori T, Saji S, Seiki M, et al. (2001) Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma. Cancer 92: 1085-1091.
41. Bieche I, Chavey C, Andrieu C, Busson M, Vacher S, et al. (2007) CXC chemokines located in the 4q21 region are up-regulated in breast cancer. Endocr Relat Cancer; 14: 1039-52.
42. Quesenberry PJ, Gimbrone MA Jr, (1980) Vascular endothelium as a regulator of granulopoiesis: production of colony-stimulating activity by cultured human endothelial cells. Blood 56 (6): 1060-1067.
43. Lenhoff S, Olofsson T, (1996) Cytokine regulation of GM-CSF and G-CSF secretion by human umbilical cord vein endothelial cells (HUVEC). Cytokine. 8 pp. 702-709.
44. Hamilton JA, (2002) GM-CSF in inflammation and autoimmunity. Trends Immunol 23: 403-408.
45. Park BK, Zhang H, Zeng Q, Dai J, Keller ET, et al. (2007) NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat Med 13: 62-69.
46. Karsan A, Yee E, Harlan JM, (1996) Endothelial cell death induced by tumor necrosis factor-alpha is inhibited by the Bcl-2 family member, A1. J Biol Chem 271: 27201-27204.
47. Karsan A, Yee E, Kaushansky K, Harlan JM, (1996) Cloning of human Bcl-2 homologue: inflammatory cytokines induce human A1 in cultured endothelial cells. Blood 87: 3089-3096.
48. Stroka DM, Badrichani AZ, Bach FH, Ferran C, (1999) Overexpression of A1, an NF-kappa B-inducible anti-apoptotic bcl gene, inhibits endothelial cell activation. Blood 93: 3803-3810.
49. Karl E, Warner K, Zeitlin B, Kaneko T, Wurtzel L, et al. (2005) Bcl-2 acts in a proangiogenic signalling pathway through nuclear factor-kappa B and CXC chemokines. Cancer Res 65: 5063-5069.
50. Marui N, Medford RM, Ahmad M, (2005) Activation of RelA homodimers by tumour necrosis factor alpha: a possible transcriptional activator in human vascular endothelial cells. Biochem J 390: 317-324.
51. Schumm K, Rocha S, Caamano J, Perkins ND, (2006) Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit. EMBO J. 25 (20): 4820-4832.
52. Gasparini C, Foxwell BM, Feldmann M, (2009) RelB/p50 regulates CCL19 production, but fails to promote human DC maturation. Eur J Immunol 39 (8): 2215-2223.
53. Cogswell PC, Guttridge DC, Funkhouser WK, Baldwin AS Jr, (2000) Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3. Oncogene. 19: 1123-1131.
54. Kim DW, Sovak MA, Zanieski G, Nonet G, Romieu-Mourez R, et al. (2000) Activation of NF-kappa B/Rel occurs early during neoplastic transformation of mammary cells. Carcinogenesis 21: 871-879.
55. Cao Y, Karin M, (2003) NF-kappa B in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 8: 215-223.
56. Folkman J, (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31 Review.
57. Yoshida S, Ono M, Shono T, Izumi H, Ishibashi T, et al. (1997) Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol 17: 4015-4023.